Epidermal cytoplasmic antigens: II. Concurrent presence of antigens of different specificities in normal human skin.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 79622)

Published in J Invest Dermatol on August 01, 1978

Authors

J C Bystryn, M Nash, P Robins

Articles by these authors

(truncated to the top 100)

Complementation of the xeroderma pigmentosum DNA repair defect in cell-free extracts. Cell (1988) 4.28

Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature (1997) 3.64

Active site and complete sequence of the suicidal methyltransferase that counters alkylation mutagenesis. Proc Natl Acad Sci U S A (1985) 3.01

Molecular cloning and expression of human cDNAs encoding a novel DNA ligase IV and DNA ligase III, an enzyme active in DNA repair and recombination. Mol Cell Biol (1995) 2.61

Repair of alkylated DNA in Escherichia coli. Physical properties of O6-methylguanine-DNA methyltransferase. J Biol Chem (1982) 2.56

Uracil-DNA glycosylase (UNG)-deficient mice reveal a primary role of the enzyme during DNA replication. Mol Cell (2000) 2.54

Prognostic significance of hypopigmentation in malignant melanoma. Arch Dermatol (1987) 2.51

A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein. EMBO J (1999) 2.04

Suicide inactivation of the E. coli O6-methylguanine-DNA methyltransferase. EMBO J (1982) 2.03

Immunofluorescence abnormalities in lichen planopilaris. Arch Dermatol (1992) 2.02

Implementing a "Do-Not-Resuscitate" (DNR) policy in a nursing home. J Am Geriatr Soc (1989) 2.00

Cervical Chlamydia trachomatis and mycoplasmal infections in pregnancy. Epidemiology and outcomes. JAMA (1983) 1.89

Isolation of mutants of Escherichia coli with increased resistance to alkylating agents: mutants deficient in thiols and mutants constitutive for the adaptive response. Mol Gen Genet (1980) 1.86

Excision of deaminated cytosine from the vertebrate genome: role of the SMUG1 uracil-DNA glycosylase. EMBO J (2001) 1.85

Molecular characterization of a human DNA kinase. J Biol Chem (1999) 1.83

Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N Engl J Med (1999) 1.81

Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion. J Exp Med (1970) 1.70

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Functional domains and methyl acceptor sites of the Escherichia coli ada protein. J Biol Chem (1988) 1.58

Endothelial dysfunction late after Kawasaki disease. Circulation (1996) 1.53

Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study. Blood (1997) 1.51

The inducible repair of alkylated DNA. Prog Nucleic Acid Res Mol Biol (1981) 1.51

Antibodies to normal human melanocytes in vitiligo. J Exp Med (1983) 1.50

Factors influencing satisfaction and anticipated turnover for nurses in an academic medical center. J Nurs Adm (2001) 1.45

Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study. Leukemia (1998) 1.43

Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus. Arch Dermatol (2000) 1.42

Cross-linking of DNA induced by chloroethylnitrosourea is presented by O6-methylguanine-DNA methyltransferase. Nucleic Acids Res (1983) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res (1991) 1.40

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Mohs micrographic surgery. J Dermatol Surg Oncol (1993) 1.39

Association of tissue-fixed cytoplasmic deposits of immunoglobulin in epidermal keratinocytes with lupus erythematosus. Arch Dermatol (1993) 1.38

Silver spoons: supervised volunteers provide feeding of patients. Geriatr Nurs (1997) 1.37

Identification of a 160-kD molecule as a component of the basement membrane zone and as a minor bullous pemphigoid antigen. J Invest Dermatol (1990) 1.36

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Effect of exogenous DNA fragments on human cell extract-mediated DNA repair synthesis. Mutat Res (1991) 1.30

Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Ann Intern Med (1989) 1.28

Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27

Oxygen free radical damage to DNA. Translesion synthesis by human DNA polymerase eta and resistance to exonuclease action at cyclopurine deoxynucleoside residues. J Biol Chem (2001) 1.22

Pemphigus foliaceus. Subcorneal intercellular antibodies of unique specificity. Arch Dermatol (1974) 1.20

Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19

Epidermolysis bullosa acquisita. Incidence in patients with basement membrane zone antibodies. Arch Dermatol (1990) 1.19

S1 nuclease mapping of viral RNAs from a temperature-sensitive transformation mutant of murine sarcoma virus. J Virol (1984) 1.16

Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol (1991) 1.15

Basal-cell carcinomas in the center of the face: special diagnostic, prognostic, and therapeutic considerations. J Dermatol Surg Oncol (1978) 1.15

The recurrent basal cell epithelioma. A study of 100 cases of recurrent, re-treated basal cell epitheliomas. Arch Dermatol (1971) 1.15

Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer. J Urol (2001) 1.14

Comparison of alopecia areata in human and nonhuman mammalian species. Pathobiology (1998) 1.14

Antibodies to hair follicles in alopecia areata. J Invest Dermatol (1994) 1.13

Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13

Sepcific removal of in vivo antibody by extracorporeal circulation over an immunoadsorbent in gel. J Clin Invest (1971) 1.13

Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"? Exp Dermatol (2006) 1.13

Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells. Arch Dermatol (1995) 1.12

Gadolinium-enhanced three-dimensional MR portal venography. AJR Am J Roentgenol (1999) 1.11

Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. Biochem Biophys Res Commun (2000) 1.09

Absence of intercellular antigens in the deep layers of the epidermis in pemphigus foliaceus. J Clin Invest (1978) 1.08

Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07

Epidermal cytoplasmic antibodies: incidence and type in normal persons and patients with melanoma. J Invest Dermatol (1976) 1.05

An RFLP-based genetic map of pearl millet (Pennisetum glaucum). Theor Appl Genet (1994) 1.05

HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients. J Immunol (1998) 1.05

Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05

Regional variation in the expression of bullous pemphigoid antigen and location of lesions in bullous pemphigoid. J Invest Dermatol (1984) 1.04

Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol (2000) 1.04

Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. J Invest Dermatol (1988) 1.02

Alopecia areata: an autoimmune disease? Exp Dermatol (1999) 1.01

Comparing recollective experience in true and false autobiographical memories. J Exp Psychol Learn Mem Cogn (2001) 1.01

Different active sites of mammalian DNA ligases I and II. J Biol Chem (1994) 1.01

Different populations of melanocytes are present in hair follicles and epidermis. Pigment Cell Res (1996) 1.01

Binding of antigen by immunocytes. I. Effect of ligand valence on binding affinity of MOPC 315 cells for DNP conjugates. J Exp Med (1973) 1.00

Microcystic adnexal carcinoma: collaborative series review and update. J Am Acad Dermatol (1999) 0.99

Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99

Competitive binding of xenobiotic oestrogens to rat alpha-fetoprotein and to sex steroid binding proteins in human and rainbow trout (Oncorhynchus mykiss) plasma. Gen Comp Endocrinol (1998) 0.99

On the origin of Alzheimer's disease: a hypothesis. Neuroreport (1993) 0.99

Adjuvant therapy of pemphigus. Arch Dermatol (1984) 0.99

Limitations in the diagnosis of vesiculobullous diseases. Am J Dermatopathol (1983) 0.99

Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service. Arch Dis Child (2000) 0.99

Antibodies against the cytoplasm of human epidermal cells. Arch Dermatol (1973) 0.98

Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol (1986) 0.97

Cytolytic antibodies to melanocytes in vitiligo. J Invest Dermatol (1993) 0.97

Chemosurgery: my 15 years of experience. J Dermatol Surg Oncol (1981) 0.97

Identification and solubilization of iodinated cell surface human melanoma associated antigens. Int J Cancer (1977) 0.96

Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase. Xenobiotica (2001) 0.96

Is there a role for renal scintigraphy in the routine initial evaluation of a child with a urinary infection? Pediatr Radiol (1995) 0.96

Acute postobstructive pulmonary edema. Otolaryngol Head Neck Surg (1995) 0.96

[Bowen disease of the nail apparatus. Report of 5 cases and review of the 20 cases of the literature (author's transl)]. Ann Dermatol Venereol (1979) 0.95

Identification and purification of a Mr 75,000 cell surface human melanoma-associated antigen. Cancer Res (1982) 0.95

Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Clin Cancer Res (2000) 0.93

Comparison of cell-surface human melanoma-associated antigens identified by rabbit and murine antibodies. Hybridoma (1982) 0.93

Regional variation in the expression of pemphigus foliaceus, pemphigus erythematosus, and pemphigus vulgaris antigens in human skin. J Invest Dermatol (1991) 0.93

Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosing. Xenobiotica (1994) 0.92

Identification of pigment cell antigens defined by vitiligo antibodies. J Invest Dermatol (1992) 0.92

Use of in vivo and in vitro assays for the characterization of mammalian excision repair and isolation of repair proteins. Mutat Res (1990) 0.92

Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials. J Urol (2006) 0.92

Repair of surgical defects. I. Circular defects on the forehead. J Dermatol Surg Oncol (1981) 0.92

Idiopathic microscopic polyarteritis nodosa: ultrastructural observations on the renal vascular and glomerular lesions. Am J Kidney Dis (1986) 0.92

Mohs surgery for periocular basal cell carcinomas. J Dermatol Surg Oncol (1985) 0.91

Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris. Arch Dermatol (1979) 0.91

Laryngeal tuberculosis in HIV-infected patients: a difficult diagnosis. Laryngoscope (1996) 0.91

Antibodies to melanocytes. Occurrence in patients with vitiligo and chronic mucocutaneous candidiasis. Arch Dermatol (1981) 0.90